Kancera AB operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kancera AB with three other
pharmaceutical manufacturers in Europe:
Infant Bacterial Therapeutics AB
sales of 238,000.00 Swedish Kronor [US$26,444.18 ]
Bone Therapeutics SA
(41,000.00 Euro [US$46,750.25 ]
NUTEX Investments Plc
based in Hungary
(8.76 million Hungarian Forints [US$31,010.40 ]
Kancera AB reported sales of SEK 376,000.00 (US$41.78 thousand)
December of 2017.
increase of 22.1%
versus 2016, when the company's sales were SEK 308,000.00 .